Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B. Riley Securities Maintains Neutral on Rigel Pharmaceuticals, Lowers Price Target to $1.25

B. Riley Securities analyst Kalpit Patel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and lowers the price target from $4 to $1.25.
byBenzinga Newsdesk
June 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

B. Riley Securities analyst Kalpit Patel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and lowers the price target from $4 to $1.25.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts